Univax Biologics Inc.

BY THE NUMBERS

July 25, 1992

Despite doubled revenues, this Rockville biotechnology company said yesterday that its loss tripled, to $2.5 million, or 23 cents a share, in the second quarter, which ended June 30, compared with the same period the year before.

The company attributed the loss to the growth of its work force from 25 employees to 100 this year and

the cost of adding several new products to its development plans.

Three months ended 6/30/92

KA.. ... .. .. .. .. .. Revenue .. .. .. Net .. .. .. .. .. Share

'92 .. .. .. .. .. ..711,000 .. .. ..(2,546,497) .. ..(0.23)

'91 .. .. .. .. .. ..346,443 .. .. ..(850,752) .. .. .(0.14)

% change .. .. .. .. . +105.0 .. .. .. .. .. .. -- .. .. ... --

Six months ended 6/30/92

.. .. .. .. .. .. ... Revenue .. .. .. Net .. .. .. .. .. Share

'92 .. .. .. .. .. . 922,000 .. .. ..(4,591,021) .. ..(0.44)

'91 .. .. .. .. .. .. 657,354 .. .. ..(1,269,242) .. .. (0.20)

% change .. .. .. .. .. +40.2 .. .. .. .. .. .. -- .. .. ... --

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.